This is a firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc. The contract, valued at $12,060.60, is for the delivery of medical supplies. The period of performance runs through February 1, 2024. This award does not have a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, in vitro...
This is a fixed-price purchase order awarded by the Bureau of Administration, a civilian agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the delivery of medical supplies. The contract has a ceiling value of $11,577.60 and a completion date of June 15, 2024. It is not associated with a set-aside program. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, to government agencies such as the...
This is a firm fixed-price purchase order awarded by the U.S. Bureau of Administration (a civilian federal agency) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the delivery of medical supplies. The contract has a ceiling value of $12,462.40 and a completion date of June 22, 2024. It is not designated as a set-aside award. The award is associated with Abbott Rapid DX North America LLC's existing federal contract vehicles, including a Blanket Purchase Agreement...
This is a federal purchase order contract awarded by the Bureau of Administration, a civilian agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc. The contract is for $11,901.50 and is for the delivery of medical supplies, with a completion date of September 5, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation. Abbott Rapid DX North America LLC, a major supplier of COVID-19 diagnostic products, has been awarded this...
This is a firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian federal agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract, with a ceiling value of $17,231.00 and a completion date of September 20, 2024, is for the delivery of medical supplies. The contract was awarded on August 29, 2024 and does not have a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic...
This is a $16,875.00 firm-fixed price purchase order contract awarded to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, by the Bureau of Administration, a civilian federal agency. The contract is for the delivery of medical supplies, with a completion date of January 12, 2024. It does not have a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, to various government agencies,...
This is a federal contract award to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide medical supplies for the U.S. government. The contract, valued at $10,707.00, is a firm fixed-price purchase order awarded by the Bureau of Administration, a civilian agency. The award has no set-aside designation and has an ultimate completion date of March 20, 2025. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen...
This is a federal contract award to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, by a civilian federal agency, the Bureau of Administration. The contract is for the provision of medical supplies, specifically COVID-19 diagnostic products including rapid antigen tests, in vitro diagnostics, and molecular testing platforms. The contract is a Firm Fixed Price Purchase Order with a ceiling value of $13,066.00 and an ultimate completion date of June 15, 2024. The contract...
This is a $25,081.00 firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian federal agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is for the delivery of medical supplies and has a completion date of November 16, 2024. The contract was not set aside for any specific business category. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic equipment, including BinaxNOW rapid antigen tests,...
This is a $13,866.00 firm fixed-price purchase order awarded by the Bureau of Administration to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is for the delivery of medical supplies, with a period of performance ending on June 27, 2025. This award is not designated as a set-aside contract. The primary contractor, Abbott Rapid DX North America LLC, is a major supplier of COVID-19 diagnostic equipment, including BinaxNOW rapid antigen tests, to various...